Cover Page
Cover Page - shares | 3 Months Ended | |
Mar. 31, 2024 | May 03, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2024 | |
Document Transition Report | false | |
Entity File Number | 001-31922 | |
Entity Registrant Name | TEMPUR SEALY INTERNATIONAL, INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 33-1022198 | |
Entity Address, Address Line One | 1000 Tempur Way | |
Entity Address, City or Town | Lexington | |
Entity Address, State or Province | KY | |
Entity Address, Postal Zip Code | 40511 | |
City Area Code | 800 | |
Local Phone Number | 878-8889 | |
Title of 12(b) Security | Common Stock, $0.01 par value | |
Trading Symbol | TPX | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 173,625,241 | |
Entity Central Index Key | 0001206264 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Net sales | $ 1,189.4 | $ 1,208.1 |
Cost of sales | 676.8 | 708.2 |
Gross profit | 512.6 | 499.9 |
Selling and marketing expenses | 265 | 256.7 |
General, administrative and other expenses | 121 | 104.5 |
Equity income in earnings of unconsolidated affiliates | (4.9) | (4.6) |
Operating income | 131.5 | 143.3 |
Other expense, net: | ||
Interest expense, net | 34.3 | 32.8 |
Other (income) expense, net | (0.3) | 0.1 |
Total other expense, net | 34 | 32.9 |
Income before income taxes | 97.5 | 110.4 |
Income tax provision | (20.7) | (24.5) |
Net income before non-controlling interest | 76.8 | 85.9 |
Less: Net income attributable to non-controlling interest | 0.5 | 0.6 |
Net income attributable to Tempur Sealy International, Inc. | $ 76.3 | $ 85.3 |
Earnings per common share: | ||
Basic (in dollars per share) | $ 0.44 | $ 0.50 |
Diluted (in dollars per share) | $ 0.43 | $ 0.48 |
Weighted average common shares outstanding: | ||
Basic (in shares) | 173.6 | 172 |
Diluted (in shares) | 178 | 176.8 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Statement of Comprehensive Income [Abstract] | ||
Net income before non-controlling interest | $ 76.8 | $ 85.9 |
Other comprehensive (loss) income, net of tax: | ||
Foreign currency translation adjustments | (15.5) | 14.9 |
Pension benefits loss, net of tax | (0.3) | 0 |
Other comprehensive (loss) income, net of tax | (15.8) | 14.9 |
Comprehensive income | 61 | 100.8 |
Less: Comprehensive income attributable to non-controlling interest | 0.5 | 0.6 |
Comprehensive income attributable to Tempur Sealy International, Inc. | $ 60.5 | $ 100.2 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
Current Assets: | ||
Cash and cash equivalents | $ 92.5 | $ 74.9 |
Accounts receivable, net | 483.6 | 431.4 |
Inventories | 489.6 | 483.1 |
Prepaid expenses and other current assets | 96.2 | 113.8 |
Total Current Assets | 1,161.9 | 1,103.2 |
Property, plant and equipment, net | 875.8 | 878.3 |
Goodwill | 1,077.2 | 1,083.3 |
Other intangible assets, net | 710.3 | 714.8 |
Operating lease right-of-use assets | 619.7 | 636.5 |
Deferred income taxes | 15.4 | 15.6 |
Other non-current assets | 125.5 | 122.2 |
Total Assets | 4,585.8 | 4,553.9 |
Current Liabilities: | ||
Accounts payable | 345.2 | 311.3 |
Accrued expenses and other current liabilities | 434.2 | 427.1 |
Short-term operating lease obligations | 121.5 | 119.6 |
Current portion of long-term debt | 47.3 | 44.9 |
Income taxes payable | 10 | 5.3 |
Total Current Liabilities | 958.2 | 908.2 |
Long-term debt, net | 2,526.4 | 2,527 |
Long-term operating lease obligations | 558 | 574.8 |
Deferred income taxes | 127.2 | 127.9 |
Other non-current liabilities | 80.6 | 82.6 |
Total Liabilities | 4,250.4 | 4,220.5 |
Redeemable non-controlling interest | 8.8 | 10 |
Total Stockholders' Equity | 326.6 | 323.4 |
Total Liabilities, Redeemable Non-Controlling Interest and Stockholders' Equity | $ 4,585.8 | $ 4,553.9 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) shares in Millions, $ in Millions | Total | Common Stock | Treasury Stock | Additional Paid in Capital | Retained Earnings | Accumulated Other Comprehensive Loss |
Redeemable noncontrolling interest, beginning balance at Dec. 31, 2022 | $ 9.8 | |||||
Increase (Decrease) in Temporary Equity [Roll Forward] | ||||||
Net income attributable to non-controlling interests | 0.6 | |||||
Dividend paid to non-controlling interest in subsidiary | (1.5) | |||||
Redeemable noncontrolling interest, ending balance at Mar. 31, 2023 | 8.9 | |||||
Balance at beginning of period (in shares) at Dec. 31, 2022 | 283.8 | |||||
Balance at beginning of period at Dec. 31, 2022 | (22.1) | $ 2.8 | $ (3,434.7) | $ 598.2 | $ 2,988.5 | $ (176.9) |
Balance at beginning of period (in shares) at Dec. 31, 2022 | 113.4 | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 85.3 | 85.3 | ||||
Foreign currency adjustments, net of tax | 14.9 | 14.9 | ||||
Exercise of stock options (in shares) | (0.1) | |||||
Exercise of stock options | 0.8 | $ 1.5 | (0.7) | |||
Dividends declared on common stock | (19.3) | (19.3) | ||||
Issuances of PRSUs and RSUs (in shares) | (2.6) | |||||
Issuances of PRSUs and RSUs | 0 | $ 82.6 | (82.6) | |||
Treasury stock repurchased (in shares) | 0.1 | |||||
Treasury stock repurchased | (5) | $ (5) | ||||
Treasury stock repurchased - PRSU/RSU releases (in shares) | 0.9 | |||||
Treasury stock repurchased - PRSU/RSU releases | (30.7) | $ (30.7) | ||||
Amortization of unearned stock-based compensation | 10.8 | 10.8 | ||||
Balance at end of period (in shares) at Mar. 31, 2023 | 283.8 | |||||
Balance at end of period at Mar. 31, 2023 | 34.7 | $ 2.8 | $ (3,386.3) | 525.7 | 3,054.5 | (162) |
Balance at ending of period (in shares) at Mar. 31, 2023 | 111.7 | |||||
Redeemable noncontrolling interest, beginning balance at Dec. 31, 2023 | 10 | |||||
Increase (Decrease) in Temporary Equity [Roll Forward] | ||||||
Net income attributable to non-controlling interests | 0.5 | |||||
Dividend paid to non-controlling interest in subsidiary | (1.7) | |||||
Redeemable noncontrolling interest, ending balance at Mar. 31, 2024 | 8.8 | |||||
Balance at beginning of period (in shares) at Dec. 31, 2023 | 283.8 | |||||
Balance at beginning of period at Dec. 31, 2023 | 323.4 | $ 2.8 | $ (3,380.6) | 558.7 | 3,279.2 | (136.7) |
Balance at beginning of period (in shares) at Dec. 31, 2023 | 111.5 | |||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Net income | 76.3 | 76.3 | ||||
Adjustment to Pension Liability, net of tax | (0.3) | (0.3) | ||||
Foreign currency adjustments, net of tax | (15.5) | (15.5) | ||||
Exercise of stock options | 0.3 | $ 1.3 | (1) | |||
Dividends declared on common stock | (23) | (23) | ||||
Issuances of PRSUs and RSUs (in shares) | (2.2) | |||||
Issuances of PRSUs and RSUs | 0 | $ 90.5 | (90.5) | |||
Treasury stock repurchased - PRSU/RSU releases (in shares) | 0.9 | |||||
Treasury stock repurchased - PRSU/RSU releases | (43.8) | $ (43.8) | ||||
Amortization of unearned stock-based compensation | 9.2 | 9.2 | ||||
Balance at end of period (in shares) at Mar. 31, 2024 | 283.8 | |||||
Balance at end of period at Mar. 31, 2024 | $ 326.6 | $ 2.8 | $ (3,332.6) | $ 476.4 | $ 3,332.5 | $ (152.5) |
Balance at ending of period (in shares) at Mar. 31, 2024 | 110.2 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (Parenthetical) - $ / shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Statement of Stockholders' Equity [Abstract] | ||
Dividends on common stock (in usd per share) | $ 0.13 | $ 0.11 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income before non-controlling interest | $ 76.8 | $ 85.9 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 39.2 | 33.8 |
Amortization of stock-based compensation | 9.2 | 10.8 |
Amortization of deferred financing costs | 0.9 | 1 |
Bad debt expense | 3.8 | 1.7 |
Deferred income taxes | 0.1 | 0.7 |
Dividends received from unconsolidated affiliates | 4.9 | 1.5 |
Equity income in earnings of unconsolidated affiliates | (4.9) | (4.6) |
Foreign currency adjustments and other | 0.1 | (0.8) |
Changes in operating assets and liabilities | 0.1 | (30.2) |
Net cash provided by operating activities | 130.2 | 99.8 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchases of property, plant and equipment | (31.5) | (52.1) |
Other | 0.3 | 0.1 |
Net cash used in investing activities | (31.2) | (52) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from borrowings under long-term debt obligations | 478.1 | 509.8 |
Repayments of borrowings under long-term debt obligations | (481.8) | (477.4) |
Proceeds from exercise of stock options | 0.3 | 0.8 |
Treasury stock repurchased | (43.8) | (35.7) |
Dividends paid | (24.9) | (20.8) |
Repayments of finance lease obligations and other | (5.8) | (5.1) |
Net cash used in financing activities | (77.9) | (28.4) |
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS | (3.5) | 2.2 |
Increase in cash and cash equivalents | 17.6 | 21.6 |
CASH AND CASH EQUIVALENTS, beginning of period | 74.9 | 69.4 |
CASH AND CASH EQUIVALENTS, end of period | 92.5 | 91 |
Cash paid during the period for: | ||
Interest | 20.3 | 19.5 |
Income taxes, net of refunds | $ 13.2 | $ 11.3 |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies (a) Basis of Presentation and Description of Business. Tempur Sealy International, Inc., a Delaware corporation, together with its subsidiaries, is a U.S. based, multinational company. The term "Tempur Sealy International" refers to Tempur Sealy International, Inc. only, and the term "Company" refers to Tempur Sealy International, Inc. and its consolidated subsidiaries. The Company designs, manufactures and distributes bedding products, which include mattresses, foundations and adjustable bases, and other products, which include pillows and other accessories. The Company also derives income from royalties by licensing Sealy® and Stearns & Foster® brands, technology and trademarks to other manufacturers. The Company sells its products through two sales channels: Wholesale and Direct. The Company has ownership interests in Asia-Pacific joint ventures to develop markets for Sealy® and Stearns & Foster® branded products and ownership in a United Kingdom joint venture to manufacture, market, and distribute Sealy® and Stearns & Foster® branded products. The Company's ownership interests in each of these joint ventures is 50.0%. The equity method of accounting is used for these joint ventures, over which the Company has significant influence but does not have control, and consolidation is not otherwise required. The Company's equity in the net income and losses of these investments is reported in equity income in earnings of unconsolidated affiliates in the accompanying Condensed Consolidated Statements of Income. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States ("GAAP") for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements of the Company and related footnotes for the year ended December 31, 2023, included in the 2023 Annual Report filed with the Securities and Exchange Commission on February 16, 2024. The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein. (b) Inventories . Inventories are stated at the lower of cost or net realizable value, determined by the first-in, first-out method, and consist of the following: March 31, December 31, (in millions) 2024 2023 Finished goods $ 350.7 $ 335.4 Work-in-process 14.8 16.5 Raw materials and supplies 124.1 131.2 $ 489.6 $ 483.1 (c) Warranties . The Company provides warranties on certain products, which vary by segment, product and brand. Estimates of warranty expenses are based primarily on historical claims experience and product testing. Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized. The Company considers the impact of recoverable salvage value on warranty costs in determining its estimate of future warranty obligations. The Company provides warranties on mattresses with varying warranty terms. Tempur-Pedic mattresses sold in the North America segment and all Sealy mattresses have warranty terms ranging from 10 to 25 years, generally non-prorated for the first 10 to 15 years and then prorated for the balance of the warranty term. Tempur-Pedic mattresses sold in the International segment have warranty terms ranging from 5 to 15 years, non-prorated for the first 5 years and then prorated on a straight-line basis for the last 10 years of the warranty term. Tempur-Pedic pillows have a warranty term of 3 years, non-prorated. The Company had the following activity for its accrued warranty expense from December 31, 2023 to March 31, 2024: (in millions) Balance as of December 31, 2023 $ 40.8 Amounts accrued 3.9 Warranties charged to accrual (3.1) Balance as of March 31, 2024 $ 41.6 As of March 31, 2024 and December 31, 2023, $19.4 million and $18.9 million of accrued warranty expense is included as a component of accrued expenses and other current liabilities and $22.2 million and $21.9 million of accrued warranty expense is included in other non-current liabilities on the Company's accompanying Condensed Consolidated Balance Sheets, respectively. (d) Allowance for Credit Losses . The allowance for credit losses is the Company's best estimate of the amount of expected lifetime credit losses in the Company's accounts receivable. The Company regularly reviews the adequacy of its allowance for credit losses. The Company estimates losses over the contractual life using assumptions to capture the risk of loss, even if remote, based principally on how long a receivable has been outstanding. As of March 31, 2024, the Company's accounts receivable were substantially current. Account balances are charged off against the allowance for credit losses after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. Other factors considered include historical write-off experience, current economic conditions and also factors such as customer credit, past transaction history with the customer and changes in customer payment terms. The allowance for credit losses is included in accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets. The Company had the following activity for its allowance for credit losses from December 31, 2023 to March 31, 2024: (in millions) Balance as of December 31, 2023 $ 66.9 Amounts accrued 3.8 Write-offs charged against the allowance (1.8) Balance as of March 31, 2024 $ 68.9 (e) Fair Value. Financial instruments, although not recorded at fair value on a recurring basis, include cash and cash equivalents, accounts receivable, accounts payable and the Company's debt obligations. The carrying value of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term maturity of those instruments. Borrowings under the 2023 Credit Agreement (as defined in Note 4, "Debt") and the securitized debt are at variable interest rates and accordingly their carrying amounts approximate fair value. The fair value of the following material financial instruments were based on Level 2 inputs, which include observable inputs estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of debt instruments. The fair values of these material financial instruments are as follows: Fair Value (in millions) March 31, 2024 December 31, 2023 2029 Senior Notes $ 726.3 $ 724.2 2031 Senior Notes $ 679.9 $ 677.6 (f) Definitive Agreement with Mattress Firm. On May 9, 2023, Tempur Sealy International and Mattress Firm entered into a definitive agreement and plan of merger (the "Merger Agreement") for a proposed business acquisition in which Tempur Sealy International, through a wholly-owned subsidiary, will acquire Mattress Firm in a transaction valued at approximately $4.0 billion. The transaction is expected to be funded by approximately $2.7 billion of cash consideration and the issuance of 34.2 million shares of common stock resulting in a total stock consideration value of $1.3 billion based on a closing share price of $37.62 as of May 8, 2023. |
Net Sales
Net Sales | 3 Months Ended |
Mar. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Net Sales | Net Sales The following table presents the Company's disaggregated revenue by channel and geographical region, including a reconciliation of disaggregated revenue by segment, for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 (in millions) North America International Consolidated North America International Consolidated Channel Wholesale $ 776.9 $ 108.9 $ 885.8 $ 804.3 $ 108.3 $ 912.6 Direct 124.2 179.4 303.6 115.3 180.2 295.5 Net sales $ 901.1 $ 288.3 $ 1,189.4 $ 919.6 $ 288.5 $ 1,208.1 North America International Consolidated North America International Consolidated Geographical region United States $ 833.2 $ — $ 833.2 $ 854.9 $ — $ 854.9 All Other 67.9 288.3 356.2 64.7 288.5 353.2 Net sales $ 901.1 $ 288.3 $ 1,189.4 $ 919.6 $ 288.5 $ 1,208.1 Substantially all revenue is associated with bedding product sales. |
Goodwill
Goodwill | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill | Goodwill The following summarizes changes to the Company's goodwill, by segment: (in millions) North America International Consolidated Balance as of December 31, 2023 $ 609.7 $ 473.6 $ 1,083.3 Foreign currency translation and other (1.2) (4.9) (6.1) Balance as of March 31, 2024 $ 608.5 $ 468.7 $ 1,077.2 |
Debt
Debt | 3 Months Ended |
Mar. 31, 2024 | |
Debt Disclosure [Abstract] | |
Debt | Debt Debt for the Company consists of the following: March 31, 2024 December 31, 2023 (in millions, except percentages) Amount Rate Amount Rate Maturity Date 2023 Credit Agreement: Term A Facility $ 493.8 (1) $ 500.0 (1) October 10, 2028 Revolver 177.0 (1) 183.0 (1) October 10, 2028 2031 Senior Notes 800.0 3.875% 800.0 3.875% October 15, 2031 2029 Senior Notes 800.0 4.000% 800.0 4.000% April 15, 2029 Securitized debt 165.0 (2) 157.6 (2) April 7, 2025 Finance lease obligations (3) 96.8 92.1 Various Other 61.8 60.9 Various Total debt 2,594.4 2,593.6 Less: Deferred financing costs 20.7 21.7 Total debt, net 2,573.7 2,571.9 Less: Current portion 47.3 44.9 Total long-term debt, net $ 2,526.4 $ 2,527.0 (1) Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.625%. (2) Interest at one month SOFR index plus 10 basis points of credit spread adjustment, plus 85 basis points. (3) New finance lease obligations are a non-cash financing activity. As of March 31, 2024, the Company was in compliance with all applicable debt covenants. 2023 Credit Agreement On October 10, 2023, the Company entered into the 2023 Credit Agreement with a syndicate of banks. The 2023 Credit Agreement provides for a $1.15 billion revolving credit facility, a $500.0 million term loan facility, and an incremental facility in an aggregate amount of up to the greater of $850.0 million and additional amounts subject to the conditions set forth in the 2023 Credit Agreement, plus the amount of certain prepayments, plus an additional unlimited amount subject to compliance with a maximum consolidated secured leverage ratio test. The 2023 Credit Agreement has a $60.0 million sub-facility for the issuance of letters of credit. On February 6, 2024, the Company and certain other parties thereto entered into an amendment to the 2023 Credit Agreement which provides for a $625.0 million delayed draw term loan and a $40.0 million increase in availability on the existing revolving loan. Once drawn, the instruments will have the same terms and conditions as the Company's existing term loans and revolving loans, respectively, under the 2023 Credit Agreement. This amendment was executed in connection with the Company's financing strategy for the pending acquisition of Mattress Firm expected to close in the second half of 2024. The Company had $177.0 million in outstanding borrowings under the revolving credit facility as of March 31, 2024. Total availability under the revolving facility was $1,012.4 million, after a $0.6 million reduction for outstanding letters of credit, as of March 31, 2024. Securitized Debt The Company and certain of its subsidiaries are party to a securitization transaction with respect to certain accounts receivable due to the Company and certain of its subsidiaries (as amended, the "Accounts Receivable Securitization"). As of March 31, 2024, the Company did not have availability under the Accounts Receivable Securitization. While subject to a $200.0 million overall limit, the availability of revolving loans varies over the course of the year based on the seasonality of the Company's accounts receivable. |
Stockholders' Equity
Stockholders' Equity | 3 Months Ended |
Mar. 31, 2024 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Stockholders' Equity (a) Treasury Stock. As of March 31, 2024, the Company had approximately $774.5 million remaining under its share repurchase authorization. The Company did not repurchase shares under the program during the three months ended March 31, 2024. The Company repurchased 0.1 million shares under the program for approximately $5.0 million during the three months ended March 31, 2023. In addition, the Company acquired shares upon the vesting of certain restricted stock units ("RSUs") and performance restricted stock units ("PRSUs"), which were withheld to satisfy tax withholding obligations during each of the three months ended March 31, 2024 and 2023, respectively. The shares withheld were valued at the closing price of the stock on the New York Stock Exchange on the vesting date or first business day prior to vesting, resulting in $43.8 million and $30.7 million in treasury stock acquired during the three months ended March 31, 2024 and 2023, respectively. (b) Accumulated Other Comprehensive Loss ("AOCL"). AOCL consisted of the following: Three Months Ended March 31, (in millions) 2024 2023 Foreign Currency Translation Balance at beginning of period $ (135.5) $ (175.3) Other comprehensive loss: Foreign currency translation adjustments (1) (15.5) 14.9 Balance at end of period $ (151.0) $ (160.4) Pensions Balance at beginning of period $ (1.2) $ (1.6) Other comprehensive loss: Net change from period revaluations (2) (0.3) — Balance at end of period $ (1.5) $ (1.6) (1) In 2024 and 2023, there were no tax impacts related to foreign currency translation adjustments and no amounts were reclassified to earnings. (2) In 2024, there were no tax impacts related to pension adjustments. |
Other Items
Other Items | 3 Months Ended |
Mar. 31, 2024 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
Other Items | Other Items Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following: (in millions) March 31, 2024 December 31, 2023 Wages and benefits $ 81.1 $ 102.1 Unearned revenue 74.9 53.3 Advertising 45.0 62.6 Taxes 24.4 15.4 Other 208.8 193.7 $ 434.2 $ 427.1 |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation The Company's stock-based compensation expense for the three months ended March 31, 2024 and 2023 included PRSUs, non-qualified stock options and RSUs. A summary of the Company's stock-based compensation expense is presented in the following table: Three Months Ended March 31, (in millions) 2024 2023 PRSU expense $ 4.1 $ 5.1 Option expense 0.6 0.6 RSU expense 4.5 5.1 Total stock-based compensation expense $ 9.2 $ 10.8 The Company grants PRSUs to executive officers and certain members of management. Actual payout under the PRSUs is dependent upon the achievement of certain financial goals. During the first quarter of 2024, the Company granted PRSUs as a component of the long-term incentive plan ("2024 PRSUs"). The Company has recorded stock-based compensation expense related to the 2024 PRSUs during the three months ended March 31, 2024, as it was probable that the Company would achieve the specified performance targets for the performance period. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The Company is involved in various legal and administrative proceedings incidental to the operations of its business. The Company believes that the outcome of all such pending proceedings in the aggregate will not have a material adverse effect on its business, financial condition, liquidity or operating results. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2024 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company's effective tax rates for the three months ended March 31, 2024 and 2023 were 21.2% and 22.2%, respectively. The Company's effective tax rates for the three months ended March 31, 2024 and 2023 differed from the U.S. federal statutory rate of 21.0% principally due to subpart F income (i.e., global intangible low-taxed income, or "GILTI," earned by the Company's foreign subsidiaries), foreign income tax rate differentials, state and local taxes, changes in the Company's uncertain tax positions, the excess tax benefit related to stock-based compensation and certain other permanent items. The OECD (Organization for Economic Co-operation and Development) has proposed a global minimum effective tax of 15% on income arising in each jurisdiction ("Pillar 2") that has been agreed upon in principle by over 140 countries. During 2023, many countries took steps to incorporate Pillar 2 model rule concepts into their domestic laws. Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2. Accordingly, we still are evaluating the potential consequences of Pillar 2 on our longer-term financial position. In 2024, we do not expect Pillar 2 to have a material impact on our financial results. |
Earnings Per Common Share
Earnings Per Common Share | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
Earnings Per Common Share | Earnings Per Common Share The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for net income attributable to Tempur Sealy International: Three Months Ended March 31, (in millions, except per common share amounts) 2024 2023 Numerator: Net income attributable to Tempur Sealy International, Inc. $ 76.3 $ 85.3 Denominator: Denominator for basic earnings per common share-weighted average shares 173.6 172.0 Effect of dilutive securities 4.4 4.8 Denominator for diluted earnings per common share-adjusted weighted average shares 178.0 176.8 Basic earnings per common share $ 0.44 $ 0.50 Diluted earnings per common share $ 0.43 $ 0.48 The Company excludes shares issuable upon exercise of outstanding stock options from the diluted earnings per common share computation because their exercise price was greater than the average market price of Tempur Sealy International's common stock or they were otherwise anti-dilutive. As a result, the Company excluded an immaterial amount of shares for the three months ended March 31, 2024 and excluded 0.6 million shares for the three months ended March 31, 2023 . Holders of non-vested stock-based compensation awards do not have voting rights but do participate in dividend equivalents distributed upon the award vesting. |
Business Segment Information
Business Segment Information | 3 Months Ended |
Mar. 31, 2024 | |
Segment Reporting [Abstract] | |
Business Segment Information | Business Segment Information The Company operates in two segments: North America and International. These segments are strategic business units that are managed separately based on geography. The North America segment consists of manufacturing and distribution subsidiaries and licensees located in the U.S., Canada and Mexico. The International segment consists of manufacturing and distribution subsidiaries, joint ventures and licensees located in Europe, Asia-Pacific and Latin America (other than Mexico). The Company evaluates segment performance based on net sales, gross profit and operating income. The Company's North America and International segment assets include investments in subsidiaries that are appropriately eliminated in the Company's accompanying Condensed Consolidated Financial Statements. The remaining inter-segment eliminations are comprised of intercompany accounts receivable and payable. The following table summarizes total assets by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 5,491.1 $ 5,291.0 International 1,437.9 1,405.2 Corporate 1,379.8 1,269.5 Inter-segment eliminations (3,723.0) (3,411.8) Total assets $ 4,585.8 $ 4,553.9 The following table summarizes property, plant and equipment, net, by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 750.2 $ 753.8 International 89.7 91.3 Corporate 35.9 33.2 Total property, plant and equipment, net $ 875.8 $ 878.3 The following table summarizes operating lease right-of-use assets by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 446.5 $ 453.5 International 170.7 180.2 Corporate 2.5 2.8 Total operating lease right-of-use assets $ 619.7 $ 636.5 The following table summarizes segment information for the three months ended March 31, 2024: (in millions) North America International Corporate Eliminations Consolidated Net sales $ 901.1 $ 288.3 $ — $ — $ 1,189.4 Inter-segment sales $ 0.3 $ 0.1 $ — $ (0.4) $ — Inter-segment royalty expense (income) 7.4 (7.4) — — — Gross profit 352.8 159.8 — — 512.6 Operating income (loss) 134.4 44.8 (47.7) — 131.5 Income (loss) before income taxes 131.4 47.7 (81.6) — 97.5 Depreciation and amortization (1) $ 30.7 $ 6.5 $ 11.2 $ — $ 48.4 Capital expenditures 20.7 6.2 4.6 — 31.5 (1) Depreciation and amortization includes stock-based compensation amortization expense. The following table summarizes segment information for the three months ended March 31, 2023: (in millions) North America International Corporate Eliminations Consolidated Net sales $ 919.6 $ 288.5 $ — $ — $ 1,208.1 Inter-segment sales $ 0.3 $ — $ — $ (0.3) $ — Inter-segment royalty expense (income) 7.4 (7.4) — — — Gross profit 344.0 155.9 — — 499.9 Operating income (loss) 136.0 44.2 (36.9) — 143.3 Income (loss) before income taxes 134.2 43.0 (66.8) — 110.4 Depreciation and amortization (1) $ 25.5 $ 6.5 $ 12.6 $ — $ 44.6 Capital expenditures 45.8 4.7 1.6 — 52.1 (1) Depreciation and amortization includes stock-based compensation amortization expense. The following table summarizes property, plant and equipment, net by geographic region: (in millions) March 31, 2024 December 31, 2023 United States $ 763.7 $ 764.1 All other 112.1 114.2 Total property, plant and equipment, net $ 875.8 $ 878.3 The following table summarizes operating lease right-of-use assets by geographic region: (in millions) March 31, 2024 December 31, 2023 United States $ 437.5 $ 444.2 United Kingdom 137.5 146.5 All other 44.7 45.8 Total operating lease right-of-use assets $ 619.7 $ 636.5 |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ 76.3 | $ 85.3 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Mar. 31, 2024 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation and Description of Business | Basis of Presentation and Description of Business. Tempur Sealy International, Inc., a Delaware corporation, together with its subsidiaries, is a U.S. based, multinational company. The term "Tempur Sealy International" refers to Tempur Sealy International, Inc. only, and the term "Company" refers to Tempur Sealy International, Inc. and its consolidated subsidiaries. The Company designs, manufactures and distributes bedding products, which include mattresses, foundations and adjustable bases, and other products, which include pillows and other accessories. The Company also derives income from royalties by licensing Sealy® and Stearns & Foster® brands, technology and trademarks to other manufacturers. The Company sells its products through two sales channels: Wholesale and Direct. The Company has ownership interests in Asia-Pacific joint ventures to develop markets for Sealy® and Stearns & Foster® branded products and ownership in a United Kingdom joint venture to manufacture, market, and distribute Sealy® and Stearns & Foster® branded products. The Company's ownership interests in each of these joint ventures is 50.0%. The equity method of accounting is used for these joint ventures, over which the Company has significant influence but does not have control, and consolidation is not otherwise required. The Company's equity in the net income and losses of these investments is reported in equity income in earnings of unconsolidated affiliates in the accompanying Condensed Consolidated Statements of Income. The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X and include all of the information and disclosures required by generally accepted accounting principles in the United States ("GAAP") for interim financial reporting. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements of the Company and related footnotes for the year ended December 31, 2023, included in the 2023 Annual Report filed with the Securities and Exchange Commission on February 16, 2024. The results of operations for the interim periods are not necessarily indicative of results of operations for a full year. It is the opinion of management that all necessary adjustments for a fair presentation of the results of operations for the interim periods have been made and are of a recurring nature unless otherwise disclosed herein. |
Inventories | Inventories |
Warranties | Warranties . The Company provides warranties on certain products, which vary by segment, product and brand. Estimates of warranty expenses are based primarily on historical claims experience and product testing. Estimated future obligations related to these products are charged to cost of sales in the period in which the related revenue is recognized. The Company considers the impact of recoverable salvage value on warranty costs in determining its estimate of future warranty obligations. The Company provides warranties on mattresses with varying warranty terms. Tempur-Pedic mattresses sold in the North America segment and all Sealy mattresses have warranty terms ranging from 10 to 25 years, generally non-prorated for the first 10 to 15 years and then prorated for the balance of the warranty term. Tempur-Pedic mattresses sold in the International segment have warranty terms ranging from 5 to 15 years, non-prorated for the first 5 years and then prorated on a straight-line basis for the last 10 years of the warranty term. Tempur-Pedic pillows have a warranty term of 3 years, non-prorated. |
Allowance for Credit Losses | Allowance for Credit Losses . The allowance for credit losses is the Company's best estimate of the amount of expected lifetime credit losses in the Company's accounts receivable. The Company regularly reviews the adequacy of its allowance for credit losses. The Company estimates losses over the contractual life using assumptions to capture the risk of loss, even if remote, based principally on how long a receivable has been outstanding. As of March 31, 2024, the Company's accounts receivable were substantially current. Account balances are charged off against the allowance for credit losses after all reasonable means of collection have been exhausted and the potential for recovery is considered remote. Other factors considered include historical write-off experience, current economic conditions and also factors such as customer credit, past transaction history with the customer and changes in customer payment terms. The allowance for credit losses is included in accounts receivable, net in the accompanying Condensed Consolidated Balance Sheets. |
Fair Value | Fair Value. Financial instruments, although not recorded at fair value on a recurring basis, include cash and cash equivalents, accounts receivable, accounts payable and the Company's debt obligations. The carrying value of cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short-term maturity of those instruments. Borrowings under the 2023 Credit Agreement (as defined in Note 4, "Debt") and the securitized debt are at variable interest rates and accordingly their carrying amounts approximate fair value. The fair value of the following material financial instruments were based on Level 2 inputs, which include observable inputs estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of debt instruments. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Schedule of Inventory | Inventories are stated at the lower of cost or net realizable value, determined by the first-in, first-out method, and consist of the following: March 31, December 31, (in millions) 2024 2023 Finished goods $ 350.7 $ 335.4 Work-in-process 14.8 16.5 Raw materials and supplies 124.1 131.2 $ 489.6 $ 483.1 |
Summary of Warranty Activity | The Company had the following activity for its accrued warranty expense from December 31, 2023 to March 31, 2024: (in millions) Balance as of December 31, 2023 $ 40.8 Amounts accrued 3.9 Warranties charged to accrual (3.1) Balance as of March 31, 2024 $ 41.6 |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles | The Company had the following activity for its allowance for credit losses from December 31, 2023 to March 31, 2024: (in millions) Balance as of December 31, 2023 $ 66.9 Amounts accrued 3.8 Write-offs charged against the allowance (1.8) Balance as of March 31, 2024 $ 68.9 |
Schedule of Long Term Debt | The fair values of these material financial instruments are as follows: Fair Value (in millions) March 31, 2024 December 31, 2023 2029 Senior Notes $ 726.3 $ 724.2 2031 Senior Notes $ 679.9 $ 677.6 |
Net Sales (Tables)
Net Sales (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Revenue from Contract with Customer [Abstract] | |
Disaggregation of Revenue | The following table presents the Company's disaggregated revenue by channel and geographical region, including a reconciliation of disaggregated revenue by segment, for the three months ended March 31, 2024 and 2023: Three Months Ended March 31, 2024 Three Months Ended March 31, 2023 (in millions) North America International Consolidated North America International Consolidated Channel Wholesale $ 776.9 $ 108.9 $ 885.8 $ 804.3 $ 108.3 $ 912.6 Direct 124.2 179.4 303.6 115.3 180.2 295.5 Net sales $ 901.1 $ 288.3 $ 1,189.4 $ 919.6 $ 288.5 $ 1,208.1 North America International Consolidated North America International Consolidated Geographical region United States $ 833.2 $ — $ 833.2 $ 854.9 $ — $ 854.9 All Other 67.9 288.3 356.2 64.7 288.5 353.2 Net sales $ 901.1 $ 288.3 $ 1,189.4 $ 919.6 $ 288.5 $ 1,208.1 |
Goodwill (Tables)
Goodwill (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill by Business Segment | The following summarizes changes to the Company's goodwill, by segment: (in millions) North America International Consolidated Balance as of December 31, 2023 $ 609.7 $ 473.6 $ 1,083.3 Foreign currency translation and other (1.2) (4.9) (6.1) Balance as of March 31, 2024 $ 608.5 $ 468.7 $ 1,077.2 |
Debt (Tables)
Debt (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Debt Disclosure [Abstract] | |
Schedule of Line of Credit Facilities | Debt for the Company consists of the following: March 31, 2024 December 31, 2023 (in millions, except percentages) Amount Rate Amount Rate Maturity Date 2023 Credit Agreement: Term A Facility $ 493.8 (1) $ 500.0 (1) October 10, 2028 Revolver 177.0 (1) 183.0 (1) October 10, 2028 2031 Senior Notes 800.0 3.875% 800.0 3.875% October 15, 2031 2029 Senior Notes 800.0 4.000% 800.0 4.000% April 15, 2029 Securitized debt 165.0 (2) 157.6 (2) April 7, 2025 Finance lease obligations (3) 96.8 92.1 Various Other 61.8 60.9 Various Total debt 2,594.4 2,593.6 Less: Deferred financing costs 20.7 21.7 Total debt, net 2,573.7 2,571.9 Less: Current portion 47.3 44.9 Total long-term debt, net $ 2,526.4 $ 2,527.0 (1) Interest at SOFR index plus 10 basis points of credit spread adjustment, plus applicable margin of 1.625%. (2) Interest at one month SOFR index plus 10 basis points of credit spread adjustment, plus 85 basis points. (3) New finance lease obligations are a non-cash financing activity. |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Stockholders' Equity Note [Abstract] | |
Changes in Accumulated Other Comprehensive Loss | Accumulated Other Comprehensive Loss ("AOCL"). AOCL consisted of the following: Three Months Ended March 31, (in millions) 2024 2023 Foreign Currency Translation Balance at beginning of period $ (135.5) $ (175.3) Other comprehensive loss: Foreign currency translation adjustments (1) (15.5) 14.9 Balance at end of period $ (151.0) $ (160.4) Pensions Balance at beginning of period $ (1.2) $ (1.6) Other comprehensive loss: Net change from period revaluations (2) (0.3) — Balance at end of period $ (1.5) $ (1.6) (1) In 2024 and 2023, there were no tax impacts related to foreign currency translation adjustments and no amounts were reclassified to earnings. (2) In 2024, there were no tax impacts related to pension adjustments. |
Other Items (Tables)
Other Items (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Accrued Liabilities and Other Liabilities [Abstract] | |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following: (in millions) March 31, 2024 December 31, 2023 Wages and benefits $ 81.1 $ 102.1 Unearned revenue 74.9 53.3 Advertising 45.0 62.6 Taxes 24.4 15.4 Other 208.8 193.7 $ 434.2 $ 427.1 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Stock-Based Compensation Expense | A summary of the Company's stock-based compensation expense is presented in the following table: Three Months Ended March 31, (in millions) 2024 2023 PRSU expense $ 4.1 $ 5.1 Option expense 0.6 0.6 RSU expense 4.5 5.1 Total stock-based compensation expense $ 9.2 $ 10.8 |
Earnings Per Common Share (Tabl
Earnings Per Common Share (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Common Share | The following table sets forth the components of the numerator and denominator for the computation of basic and diluted earnings per share for net income attributable to Tempur Sealy International: Three Months Ended March 31, (in millions, except per common share amounts) 2024 2023 Numerator: Net income attributable to Tempur Sealy International, Inc. $ 76.3 $ 85.3 Denominator: Denominator for basic earnings per common share-weighted average shares 173.6 172.0 Effect of dilutive securities 4.4 4.8 Denominator for diluted earnings per common share-adjusted weighted average shares 178.0 176.8 Basic earnings per common share $ 0.44 $ 0.50 Diluted earnings per common share $ 0.43 $ 0.48 |
Business Segment Information (T
Business Segment Information (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Segment Reporting [Abstract] | |
Total Assets and Long-Lived Assets by Segment | The following table summarizes total assets by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 5,491.1 $ 5,291.0 International 1,437.9 1,405.2 Corporate 1,379.8 1,269.5 Inter-segment eliminations (3,723.0) (3,411.8) Total assets $ 4,585.8 $ 4,553.9 The following table summarizes property, plant and equipment, net, by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 750.2 $ 753.8 International 89.7 91.3 Corporate 35.9 33.2 Total property, plant and equipment, net $ 875.8 $ 878.3 The following table summarizes operating lease right-of-use assets by segment: (in millions) March 31, 2024 December 31, 2023 North America $ 446.5 $ 453.5 International 170.7 180.2 Corporate 2.5 2.8 Total operating lease right-of-use assets $ 619.7 $ 636.5 |
Segment Financial Information | The following table summarizes segment information for the three months ended March 31, 2024: (in millions) North America International Corporate Eliminations Consolidated Net sales $ 901.1 $ 288.3 $ — $ — $ 1,189.4 Inter-segment sales $ 0.3 $ 0.1 $ — $ (0.4) $ — Inter-segment royalty expense (income) 7.4 (7.4) — — — Gross profit 352.8 159.8 — — 512.6 Operating income (loss) 134.4 44.8 (47.7) — 131.5 Income (loss) before income taxes 131.4 47.7 (81.6) — 97.5 Depreciation and amortization (1) $ 30.7 $ 6.5 $ 11.2 $ — $ 48.4 Capital expenditures 20.7 6.2 4.6 — 31.5 (1) Depreciation and amortization includes stock-based compensation amortization expense. The following table summarizes segment information for the three months ended March 31, 2023: (in millions) North America International Corporate Eliminations Consolidated Net sales $ 919.6 $ 288.5 $ — $ — $ 1,208.1 Inter-segment sales $ 0.3 $ — $ — $ (0.3) $ — Inter-segment royalty expense (income) 7.4 (7.4) — — — Gross profit 344.0 155.9 — — 499.9 Operating income (loss) 136.0 44.2 (36.9) — 143.3 Income (loss) before income taxes 134.2 43.0 (66.8) — 110.4 Depreciation and amortization (1) $ 25.5 $ 6.5 $ 12.6 $ — $ 44.6 Capital expenditures 45.8 4.7 1.6 — 52.1 (1) Depreciation and amortization includes stock-based compensation amortization expense. |
Long-Lived Assets by Geographic Region | The following table summarizes property, plant and equipment, net by geographic region: (in millions) March 31, 2024 December 31, 2023 United States $ 763.7 $ 764.1 All other 112.1 114.2 Total property, plant and equipment, net $ 875.8 $ 878.3 The following table summarizes operating lease right-of-use assets by geographic region: (in millions) March 31, 2024 December 31, 2023 United States $ 437.5 $ 444.2 United Kingdom 137.5 146.5 All other 44.7 45.8 Total operating lease right-of-use assets $ 619.7 $ 636.5 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 USD ($) channel | Dec. 31, 2023 USD ($) | |
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Number of products sales channels | channel | 2 | |
Asia Pacific Joint Ventures | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Ownership percentage | 50% | |
United Kingdom Joint Venture | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Ownership percentage | 50% | |
Accrued Expenses And Other Current Liabilities | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Accrued warranty expense | $ 19.4 | $ 18.9 |
Other Noncurrent Liabilities | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Accrued warranty expense | $ 22.2 | $ 21.9 |
Bedding | Non-prorated | International | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 5 years | |
Bedding | Prorated | International | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 10 years | |
Bedding | Minimum | North America | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 10 years | |
Bedding | Minimum | International | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 5 years | |
Bedding | Minimum | Non-prorated | North America | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 10 years | |
Bedding | Maximum | North America | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 25 years | |
Bedding | Maximum | International | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 15 years | |
Bedding | Maximum | Non-prorated | North America | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 15 years | |
Pillows | North America | ||
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] | ||
Warranty term (in years) | 3 years |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Schedule Of Inventory, Current (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
Accounting Policies [Abstract] | ||
Finished goods | $ 350.7 | $ 335.4 |
Work-in-process | 14.8 | 16.5 |
Raw materials and supplies | 124.1 | 131.2 |
Total | $ 489.6 | $ 483.1 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Warranty Activity (Details) - Warranty Reserves $ in Millions | 3 Months Ended |
Mar. 31, 2024 USD ($) | |
Movement in Standard Product Warranty Accrual [Roll Forward] | |
Beginning balance | $ 40.8 |
Amounts accrued | 3.9 |
Warranties charged to accrual | (3.1) |
Ending balance | $ 41.6 |
Summary of Significant Accoun_7
Summary of Significant Accounting Policies - Schedule of Allowance for Doubtful Accounts (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Accounts Receivable, Allowance for Credit Loss [Roll Forward] | ||
Beginning balance | $ 66.9 | |
Amounts accrued | 3.8 | $ 1.7 |
Write-offs charged against the allowance | (1.8) | |
Ending balance | $ 68.9 |
Summary of Significant Accoun_8
Summary of Significant Accounting Policies - Fair Value (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
2029 Senior Notes | ||
Debt Instrument [Line Items] | ||
Long-term debt, fair value | $ 726.3 | $ 724.2 |
2031 Senior Notes | ||
Debt Instrument [Line Items] | ||
Long-term debt, fair value | $ 679.9 | $ 677.6 |
Summary of Significant Accoun_9
Summary of Significant Accounting Policies - Definitive Agreement with Mattress Firm (Details) - Matress Firm - USD ($) $ / shares in Units, shares in Millions, $ in Billions | May 09, 2023 | May 08, 2023 |
Debt Instrument [Line Items] | ||
Consideration transferred | $ 4 | |
Cash consideration | $ 2.7 | |
Shares issued in acquisition (in shares) | 34.2 | |
Total stock consideration | $ 1.3 | |
Closing share price (in dollars per share) | $ 37.62 |
Net Sales - Sales (Details)
Net Sales - Sales (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Disaggregation of Revenue [Line Items] | ||
Net sales | $ 1,189.4 | $ 1,208.1 |
Operating Segments | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 1,189.4 | 1,208.1 |
Operating Segments | United States | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 833.2 | 854.9 |
Operating Segments | All Other | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 356.2 | 353.2 |
Operating Segments | Wholesale | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 885.8 | 912.6 |
Operating Segments | Direct | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 303.6 | 295.5 |
Operating Segments | North America | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 901.1 | 919.6 |
Operating Segments | North America | United States | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 833.2 | 854.9 |
Operating Segments | North America | All Other | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 67.9 | 64.7 |
Operating Segments | North America | Wholesale | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 776.9 | 804.3 |
Operating Segments | North America | Direct | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 124.2 | 115.3 |
Operating Segments | International | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 288.3 | 288.5 |
Operating Segments | International | United States | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 0 | 0 |
Operating Segments | International | All Other | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 288.3 | 288.5 |
Operating Segments | International | Wholesale | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | 108.9 | 108.3 |
Operating Segments | International | Direct | ||
Disaggregation of Revenue [Line Items] | ||
Net sales | $ 179.4 | $ 180.2 |
Goodwill (Details)
Goodwill (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2024 USD ($) | |
Goodwill [Roll Forward] | |
Beginning balance | $ 1,083.3 |
Foreign currency translation and other | (6.1) |
Ending balance | 1,077.2 |
North America | |
Goodwill [Roll Forward] | |
Beginning balance | 609.7 |
Foreign currency translation and other | (1.2) |
Ending balance | 608.5 |
International | |
Goodwill [Roll Forward] | |
Beginning balance | 473.6 |
Foreign currency translation and other | (4.9) |
Ending balance | $ 468.7 |
Debt - Schedule of Borrowings O
Debt - Schedule of Borrowings Outstanding (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | |
Long-term Debt, Current and Noncurrent [Abstract] | ||
Finance lease obligations | $ 96.8 | $ 92.1 |
Total debt | 2,594.4 | 2,593.6 |
Less: Deferred financing costs | 20.7 | 21.7 |
Total debt, net | 2,573.7 | 2,571.9 |
Less: Current portion | 47.3 | 44.9 |
Total long-term debt, net | 2,526.4 | 2,527 |
Securitized debt | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 165 | 157.6 |
Securitized debt | Secured Overnight Financing Rate (SOFR) | ||
Line of Credit Facility [Abstract] | ||
Credit spread adjustment (as a percent) | 0.10% | |
Variable rate (as a percent) | 0.85% | |
Other | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 61.8 | 60.9 |
2023 Credit Agreement | Revolving Credit Facility | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 177 | 183 |
2023 Credit Agreement | Revolving Credit Facility | LIBOR | ||
Line of Credit Facility [Abstract] | ||
Variable rate (as a percent) | 1.625% | |
2023 Credit Agreement | Term A Facility | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 493.8 | 500 |
2023 Credit Agreement | Term A Facility | LIBOR | ||
Line of Credit Facility [Abstract] | ||
Variable rate (as a percent) | 1.625% | |
2031 Senior Notes | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 800 | $ 800 |
Line of Credit Facility [Abstract] | ||
Stated percentage | 3.875% | 3.875% |
2029 Senior Notes | ||
Long-term Debt, Current and Noncurrent [Abstract] | ||
Long term debt, gross | $ 800 | $ 800 |
Line of Credit Facility [Abstract] | ||
Stated percentage | 4% | 4% |
Debt - Narrative (Details)
Debt - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Mar. 31, 2024 | Feb. 06, 2024 | Dec. 31, 2023 | Oct. 10, 2023 | |
2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Remaining borrowing capacity | $ 1,012.4 | |||
Revolving Credit Facility | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | 200 | |||
Revolving Credit Facility | 2023 Credit Agreement | ||||
Debt Instrument [Line Items] | ||||
Long term debt, gross | 177 | $ 183 | ||
Revolving Credit Facility | 2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | $ 1,150 | |||
Term Loan Facility | 2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | 500 | |||
Incremental Facility | 2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | 850 | |||
Increase in borrowing capacity | $ 40 | |||
Letter of Credit | 2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | $ 60 | |||
Proceeds from lines of credit | $ 0.6 | |||
Delayed Draw Term Loan | 2023 Credit Agreement | Line of Credit | ||||
Debt Instrument [Line Items] | ||||
Line of credit borrowing | $ 625 |
Stockholders' Equity - Narrativ
Stockholders' Equity - Narrative (Details) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Treasury stock, acquired (in shares) | 0 | 0.1 |
Value of treasury stock acquired | $ 5 | |
Performance-based Restricted Stock Units | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Value of treasury stock acquired | $ 43.8 | $ 30.7 |
February 2016 Program | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Remaining shares under share repurchase authorization | $ 774.5 |
Stockholders' Equity - AOCL (De
Stockholders' Equity - AOCL (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance at beginning of period | $ 323,400,000 | $ (22,100,000) |
Foreign currency translation adjustments | (15,500,000) | 14,900,000 |
Balance at end of period | 326,600,000 | 34,700,000 |
Foreign Currency Translation | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance at beginning of period | (135,500,000) | (175,300,000) |
Balance at end of period | (151,000,000) | (160,400,000) |
Tax expense (benefits) | 0 | 0 |
Net amount reclassified to earnings | 0 | 0 |
Pensions | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||
Balance at beginning of period | (1,200,000) | (1,600,000) |
Net change from period revaluations | (300,000) | 0 |
Balance at end of period | (1,500,000) | $ (1,600,000) |
Tax expense (benefits) | $ 0 |
Other Items (Details)
Other Items (Details) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
Accrued Liabilities and Other Liabilities [Abstract] | ||
Wages and benefits | $ 81.1 | $ 102.1 |
Unearned revenue | 74.9 | 53.3 |
Advertising | 45 | 62.6 |
Taxes | 24.4 | 15.4 |
Other | 208.8 | 193.7 |
Total accrued liabilities | $ 434.2 | $ 427.1 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 9.2 | $ 10.8 |
PRSU expense | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 4.1 | 5.1 |
Option expense | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | 0.6 | 0.6 |
RSU expense | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total stock-based compensation expense | $ 4.5 | $ 5.1 |
Income Taxes (Details)
Income Taxes (Details) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||
Effective income tax provision (as a percent) | 21.20% | 22.20% |
Earnings Per Common Share (Deta
Earnings Per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Numerator: | ||
Net income attributable to Tempur Sealy International, Inc. | $ 76.3 | $ 85.3 |
Denominator: | ||
Denominator for basic earnings per common share-weighted average shares (in shares) | 173.6 | 172 |
Effect of dilutive securities (in shares) | 4.4 | 4.8 |
Denominator for diluted earnings per common share-adjusted weighted average shares (in shares) | 178 | 176.8 |
Basic earnings per common share (in dollars per share) | $ 0.44 | $ 0.50 |
Diluted earnings per common share (in dollars per share) | $ 0.43 | $ 0.48 |
Shares excluded from diluted earnings per common share computation as anti-dilutive (in shares) | 0.6 |
Business Segment Information (D
Business Segment Information (Details) $ in Millions | 3 Months Ended | ||
Mar. 31, 2024 USD ($) segment | Mar. 31, 2023 USD ($) | Dec. 31, 2023 USD ($) | |
Segment Reporting Information [Line Items] | |||
Number of business segments | segment | 2 | ||
Segment information [Abstract] | |||
Total assets | $ 4,585.8 | $ 4,553.9 | |
Total property, plant and equipment, net | 875.8 | 878.3 | |
Operating lease assets | 619.7 | 636.5 | |
Net sales | 1,189.4 | $ 1,208.1 | |
Gross profit | 512.6 | 499.9 | |
Operating income (loss) | 131.5 | 143.3 | |
Income (loss) before income taxes | 97.5 | 110.4 | |
Depreciation and amortization | 48.4 | 44.6 | |
Capital expenditures | 31.5 | 52.1 | |
United States | |||
Segment information [Abstract] | |||
Total property, plant and equipment, net | 763.7 | 764.1 | |
Operating lease assets | 437.5 | 444.2 | |
All Other | |||
Segment information [Abstract] | |||
Total property, plant and equipment, net | 112.1 | 114.2 | |
United Kingdom | |||
Segment information [Abstract] | |||
Operating lease assets | 137.5 | 146.5 | |
All other | |||
Segment information [Abstract] | |||
Operating lease assets | 44.7 | 45.8 | |
Operating Segments | |||
Segment information [Abstract] | |||
Net sales | 1,189.4 | 1,208.1 | |
Operating Segments | United States | |||
Segment information [Abstract] | |||
Net sales | 833.2 | 854.9 | |
Operating Segments | All Other | |||
Segment information [Abstract] | |||
Net sales | 356.2 | 353.2 | |
Operating Segments | North America | |||
Segment information [Abstract] | |||
Total assets | 5,491.1 | 5,291 | |
Total property, plant and equipment, net | 750.2 | 753.8 | |
Operating lease assets | 446.5 | 453.5 | |
Net sales | 901.1 | 919.6 | |
Gross profit | 352.8 | 344 | |
Operating income (loss) | 134.4 | 136 | |
Income (loss) before income taxes | 131.4 | 134.2 | |
Depreciation and amortization | 30.7 | 25.5 | |
Capital expenditures | 20.7 | 45.8 | |
Operating Segments | North America | United States | |||
Segment information [Abstract] | |||
Net sales | 833.2 | 854.9 | |
Operating Segments | North America | All Other | |||
Segment information [Abstract] | |||
Net sales | 67.9 | 64.7 | |
Operating Segments | International | |||
Segment information [Abstract] | |||
Total assets | 1,437.9 | 1,405.2 | |
Total property, plant and equipment, net | 89.7 | 91.3 | |
Operating lease assets | 170.7 | 180.2 | |
Net sales | 288.3 | 288.5 | |
Gross profit | 159.8 | 155.9 | |
Operating income (loss) | 44.8 | 44.2 | |
Income (loss) before income taxes | 47.7 | 43 | |
Depreciation and amortization | 6.5 | 6.5 | |
Capital expenditures | 6.2 | 4.7 | |
Operating Segments | International | United States | |||
Segment information [Abstract] | |||
Net sales | 0 | 0 | |
Operating Segments | International | All Other | |||
Segment information [Abstract] | |||
Net sales | 288.3 | 288.5 | |
Corporate | |||
Segment information [Abstract] | |||
Total assets | 1,379.8 | 1,269.5 | |
Total property, plant and equipment, net | 35.9 | 33.2 | |
Operating lease assets | 2.5 | 2.8 | |
Operating income (loss) | (47.7) | (36.9) | |
Income (loss) before income taxes | (81.6) | (66.8) | |
Depreciation and amortization | 11.2 | 12.6 | |
Capital expenditures | 4.6 | 1.6 | |
Inter-segment eliminations | |||
Segment information [Abstract] | |||
Total assets | (3,723) | $ (3,411.8) | |
Net sales | (0.4) | (0.3) | |
Inter-segment eliminations | North America | |||
Segment information [Abstract] | |||
Net sales | 0.3 | 0.3 | |
Inter-segment royalty expense (income) | 7.4 | 7.4 | |
Inter-segment eliminations | International | |||
Segment information [Abstract] | |||
Net sales | 0.1 | 0 | |
Inter-segment royalty expense (income) | $ (7.4) | $ (7.4) |